Edwards Lifesciences (EW) Gross Margin Growth (3y) (2012 - 2026)

Edwards Lifesciences (EW) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 63.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 17.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 21.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 15.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -324.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 56.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 311.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -164.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 124.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -324.00
Dec 31, 2025 -4,483.00
Sep 30, 2025 -298.00
Jun 30, 2025 -287.00
Mar 31, 2025 97.00
Dec 31, 2024 219.00
Sep 30, 2024 438.00
Jun 30, 2024 418.00
Mar 31, 2024 254.00
Dec 31, 2023 504.00
Sep 30, 2023 448.00
Jun 30, 2023 638.00
Mar 31, 2023 474.00
Dec 31, 2022 4,736.00
Sep 30, 2022 749.00
Jun 30, 2022 836.00
Mar 31, 2022 103.00
Dec 31, 2021 73.00
Sep 30, 2021 102.00
Jun 30, 2021 179.00